Trial shows long-term mortality for localised prostate cancer is low even if not treated with surgery

A previous shorter follow-up of the PIVOT trial found no significant difference in mortality between men who underwent surgery for localised prostate cancer and those treated with observation only.

This finding was confirmed in a longer term follow-up (up to 20 years) of the trial, which also assessed non-fatal health outcomes.

The study was recently published in the New England Journal of Medicine reported that after almost 20 years follow-up, mortality amongst men with low-risk prostate cancer was low and not significantly different between those treated with surgery and those treated with observation only.

Patient-reported outcomes of urinary incontinence and erectile/sexual dysfunction were higher amongst those undergoing surgery after 10 years but other patient-reported outcomes were not different between groups in the longer term.

Read more in our journal article reviews.

This entry was posted in Knowledge exchange, Prostate cancer, Prostate disease, Research and Evaluation. Bookmark the permalink.
Website by Essendon Creative